TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells

被引:0
|
作者
Ji, Wenmin [1 ,3 ]
Wang, Wenyan [2 ]
Wei, Yanfang [1 ]
机构
[1] Shanxi Med Univ, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China
[2] Shanxi Inst Food & Drug Control, Taiyuan 030001, Shanxi, Peoples R China
[3] Shanxi Med Univ, Hosp 1, 85 Jiefang South Rd, Taiyuan 030000, Shanxi, Peoples R China
来源
AMERICAN JOURNAL OF CANCER RESEARCH | 2023年 / 13卷 / 11期
关键词
PD-1/PD-L1; TP53TG1; immune escape; STAT pathway; colon cancer; REGULATORY T-CELLS; LONG NONCODING RNA; CD8(+) T; IMMUNOTHERAPY; COMBINATION; THERAPY; TARGET; RESISTANCE; PROGNOSIS; CD4(+);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This research is dedicated to investigating the mechanism of programmed cell death ligand 1 (PD-L1) and tumor protein 53 target gene 1 (TP53TG1) in immune regulation of colon cancer (CC). Expressions of TP53TG1, PDL1 and signal transducers and activators of transcription (STATs) in CC and their correlation were detected through bioinformatics analysis. Effects of PD-L1 and TP53TG1 on the CC were assessed by in vivo and in vitro experiments. Herein, PD-L1 level was negatively correlated with TP53TG1 expression, but was positively correlated with the levels of STATs. Both overexpressed TP53TG1 and PD-L1 antibody reversed the effects of CT26 cells on inhibiting cell proliferation, cytokine secretion and PD-L1 level, and enhancing the cytotoxicity of NK cells and CD8+ T cells. TP53TG1 reduced PD-L1 level by inactivating STATs pathway. Downregulation of PD-L1 increased cytokine secretion and T lymphocyte killing ability, promoted tumor cell apoptosis, and inhibited the tumor growth. Altogether, TP53TG1/STAT axis regulates the immunomodulatory mechanism of CC by reducing PD-L1 expression.
引用
收藏
页码:5218 / +
页数:19
相关论文
共 50 条
  • [31] Glyoxalase-1-Dependent Methylglyoxal Depletion Sustains PD-L1 Expression in Metastatic Prostate Cancer Cells: A Novel Mechanism in Cancer Immunosurveillance Escape and a Potential Novel Target to Overcome PD-L1 Blockade Resistance
    Antognelli, Cinzia
    Mandarano, Martina
    Prosperi, Enrico
    Sidoni, Angelo
    Talesa, Vincenzo Nicola
    CANCERS, 2021, 13 (12)
  • [32] Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer
    Shi, Yehui
    Fu, Ying
    Zhang, Xin
    Zhao, Gang
    Yao, Yuan
    Guo, Yan
    Ma, Gang
    Bai, Shuai
    Li, Hui
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (01) : 61 - 73
  • [33] Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer
    Yehui Shi
    Ying Fu
    Xin Zhang
    Gang Zhao
    Yuan Yao
    Yan Guo
    Gang Ma
    Shuai Bai
    Hui Li
    Cancer Immunology, Immunotherapy, 2021, 70 : 61 - 73
  • [34] The expression and analysis of PD-L1 in peripheral blood circulating tumor cells of lung cancer
    Wang, Wei
    Zhang, Tao
    FUTURE ONCOLOGY, 2021, 17 (13) : 1625 - 1635
  • [35] Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity
    Park, Su Hwan
    Lee, Juheon
    Yun, Hye Jin
    Kim, Seok-Ho
    Lee, Jong-Ho
    ANNALS OF LABORATORY MEDICINE, 2024, 44 (05) : 426 - 436
  • [36] PSEN1 is associated with colon cancer development via potential influences on PD-L1 nuclear translocation and tumor-immune interactions
    Wei, Wangzhi
    Zhang, Yu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [37] EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
    Shunli Peng
    Rong Wang
    Xiaojuan Zhang
    Yueyun Ma
    Longhui Zhong
    Ke Li
    Akihiro Nishiyama
    Sachiko Arai
    Seiji Yano
    Wei Wang
    Molecular Cancer, 18
  • [38] EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
    Peng, Shunli
    Wang, Rong
    Zhang, Xiaojuan
    Ma, Yueyun
    Zhong, Longhui
    Li, Ke
    Nishiyama, Akihiro
    Arai, Sachiko
    Yano, Seiji
    Wang, Wei
    MOLECULAR CANCER, 2019, 18 (01)
  • [39] Sunitinib inhibits PD-L1 expression in osteosarcoma by targeting STAT3 and remodels the immune system in tumor-bearing mice
    Duan, Xian Liang
    Guo, Jian Ping
    Li, Fan
    Xiu, Chao
    Wang, Hua
    FUTURE ONCOLOGY, 2020, 16 (24) : 1815 - 1824
  • [40] Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression
    Feng, Rui
    Li, Zhongxing
    Ge, Guangcheng
    Wang, Chenghao
    Jia, Yuejun
    Ouyang, Jun
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (11) : 1410 - 1420